Loading...
机构名称:
¥ 20.0

AE Adverse Event AIAN American Indian or Alaskan Native ATS American Thoracic Society BD Twice daily BDP Beclomethasone dipropionate BUD Budesonide CAT COPD Assessment Test CDR Clinical trial Diversity Rating CE Cost-effectiveness CI Confidence interval CMS Center for Medicare and Medicaid Services COPD Chronic obstructive pulmonary disease CrI Credible interval DIC Deviance information criterion DPI Dry powder inhalers EMA欧洲药物局ER欧洲呼吸社会ESRD终点肾脏疾病肾脏疾病evelly等价寿命FDA食品和药物管理局FEV 1在一个第二秒FEV 1 /FVC中强迫呼气量强制强制呼气量 /强制性生命量 /强制性活力比FF FFS FLUTICONE FUROATE FFS FFS FFS FFS FFS FFS FFS FLUTATE FP FLUTATE FP FLUTATIC FLUTATIC FLUTATIC FLUTASOSOSOSOSOSOSOSONE FLUTATIC GOL VLVER FLUTASOSOSOSOSOSOSOSOSOSOSOSON Glycopyrronium GOLD Global Initiative for Obstructive Lung Disease HCRU Health care resource utilization HD High dose HIDI Health Improvement Distribution Index HRQoL Health-Related Quality of Life I 2 Heterogeneity statistics ICER Institute for Clinical and Economic Review ICS Inhaled corticosteroid IRA Inflation Reduction Act IND Indacaterol KM Kaplan-Meier LABA Long-acting beta-agonist LAMA Long-acting毒蕈碱拮抗剂LD低剂量MCG微克MCL微层MCID MCID MCID最小临床上重要的差异MDI metered剂量吸入剂MITT MITT多重吸入器三重治疗MMRC修改医学研究委员会障碍障碍障碍率

特别评估以通知CMS药物价格谈判

特别评估以通知CMS药物价格谈判PDF文件第1页

特别评估以通知CMS药物价格谈判PDF文件第2页

特别评估以通知CMS药物价格谈判PDF文件第3页

特别评估以通知CMS药物价格谈判PDF文件第4页

特别评估以通知CMS药物价格谈判PDF文件第5页

相关文件推荐